Analysis of the Economic Viability of the Installation of a Photovoltaic System at Jorge de Abreu Regional Hospital in Sinop-MT

Brazilian consumers have the possibility to produce their own energy using renewable sources or qualified cogeneration and even provide the surplus for the distribution network of their locality, as determined by the publication of Normative Resolution 482/2012 by the National Electric Energy Agency (ANEEL). In view of this, the use of photovoltaic systems for electricity generation has grown surprisingly, reaching the mark of 8 gigawatts of installed power on Brazilian soil in the year 2021 [1]. In Brazil, public agencies represent 0.1% with 4.7MW installed [1], and in the state of Mato Grosso 0.38% [14]. Thus, aiming at the rise of electricity generation in public buildings, due to the possibility of reducing costs with the electric bill, the present work deals with the dimensioning, budget quotation and economic feasibility analysis regarding the installation of a grid-connected photovoltaic power generation system to meet the energy demands of the Jorge de Abreu Regional Hospital in the city of Sinop, Mato Grosso state, Brazil. Whose, after carrying out the necessary research based on the techniques present in the economic sciences, as Minimum Attractiveness Rate (MRA), Net Present Value (VLP), Internal Rate of Return (IRR) and calculation of Payback. The present work considered a grid-connected solar energy generation system of 585 kW to supply the hospital's average monthly consumption of 93.829 kWh/month. The investment analysis showed that the project for the implementation of the photovoltaic system will have its NPV viable from the 4th year of installation and the Payback (return on investment), observing the monetary corrections, of approximately 4,29 years, thus configuring the system as economic financially.</p

Implementation of a Brazilian Cardioprotective Nutritional (BALANCE) Program for improvement on quality of diet and secondary prevention of cardiovascular events: A randomized, multicenter trial

Background: Appropriate dietary recommendations represent a key part of secondary prevention in cardiovascular disease (CVD). We evaluated the effectiveness of the implementation of a nutritional program on quality of diet, cardiovascular events, and death in patients with established CVD. Methods: In this open-label, multicenter trial conducted in 35 sites in Brazil, we randomly assigned (1:1) patients aged 45 years or older to receive either the BALANCE Program (experimental group) or conventional nutrition advice (control group). The BALANCE Program included a unique nutritional education strategy to implement recommendations from guidelines, adapted to the use of affordable and regional foods. Adherence to diet was evaluated by the modified Alternative Healthy Eating Index. The primary end point was a composite of all-cause mortality, cardiovascular death, cardiac arrest, myocardial infarction, stroke, myocardial revascularization, amputation, or hospitalization for unstable angina. Secondary end points included biochemical and anthropometric data, and blood pressure levels. Results: From March 5, 2013, to Abril 7, 2015, a total of 2534 eligible patients were randomly assigned to either the BALANCE Program group (n = 1,266) or the control group (n = 1,268) and were followed up for a median of 3.5 years. In total, 235 (9.3%) participants had been lost to follow-up. After 3 years of follow-up, mean modified Alternative Healthy Eating Index (scale 0-70) was only slightly higher in the BALANCE group versus the control group (26.2 ± 8.4 vs 24.7 ± 8.6, P <.01), mainly due to a 0.5-serving/d greater intake of fruits and of vegetables in the BALANCE group. Primary end point events occurred in 236 participants (18.8%) in the BALANCE group and in 207 participants (16.4%) in the control group (hazard ratio, 1.15; 95% CI 0.95-1.38; P =.15). Secondary end points did not differ between groups after follow-up. Conclusions: The BALANCE Program only slightly improved adherence to a healthy diet in patients with established CVD and had no significant effect on the incidence of cardiovascular events or death. © 2019 The Author